Latest Collaborations in biotechnology NewsRSS

02:14 EDT 23rd August 2017 | BioPortfolio

Argentum Pharmaceuticals and Eli Lilly Settle Patent Dispute Over CIALIS®

NEW YORK, Aug. 22, 2017 /PRNewswire/ -- Argentum Pharmaceuticals LLC, a generic pharmaceutical company, announced that it has reached a settlement and license agreement with Eli Lilly and Company related to Argentum's generic version of CIALIS® (tadalifil). The agreement generally provides that Argentum may commence marketing its generic product no earlier than September 27, 2018. The specif...

Global Eyeglasses Industry

LONDON, Aug. 22, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Eyeglasses in Thousand Units by the following Product Segments: Lenses (Glass Lenses, Plastic Lenses, and MHI & Polycarbonate), Frames (Metal, & Plastic), and Sunglasses (Premium-Priced, & Popular-Priced).Download the full report: Lenses market is also anal...

The 13th Swedish-American Life Science Summit, taking place in Stockholm, Sweden, August 23-25, will focus on Cancer Moonshot, HealthTech Transformation and Impact Investing

STOCKHOLM, Aug. 22, 2017 /PRNewswire/ -- The Swedish-American Life Science Summit (SALSS) announced today that this year's conference will focus on Joe Biden's Cancer Moonshot, including perspectives of living with chronic disease, HealthTech Transformation, that is increasingly driven also by Technology companies and Patients, and how Impact Investing and other alternative Financing can chan...

Xerox, PARC Partners with Innovation Lab to Develop Innovation Healthcare Solutions

Xerox Corporation and PARC, A Xerox Company are teaming up with Innovation Lab, an Innovation Institute company, to tackle health care challenges through collaboration in medical technology, engineering and robotics. The Innovation Institute works with physicians, employees, and industry partners to seek new products, ideas, and concepts that can be commercialized through the Innovation Lab. ... R...

Samsung Bioepis teams with Takeda to take first steps into novel biologics space

Samsung Bioepis says it will continue focusing on biosimilars as it ventures into the innovative biologics space through a partnership with Takeda.

Caldera Medical and Accidental Sisterhood Foundation Partner to Educate Women on Pelvic Floor Health

Accidental Sisterhood and Caldera Medical today announced their partnership to educate women on the treatment options for the pelvic floor, and to reduce the suffering of women with Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP). This Smart News Release features multimedia. View the full release here:

eHealth Works With Square to Help Small Businesses Find Health Insurance Solutions

eHealth, Inc. (NASDAQ: EHTH), which operates, a leading private online health insurance exchange, announced today that it is now providing Square’s small business customers with access to a broad range of health insurance solutions as well as eHealth’s innovative plan comparison tools and robu

AstraZeneca ups its mRNA stake through €25m Ethris deal

AstraZeneca has entered a five-year collaboration to develop therapies for respiratory diseases based on Ethris’ messenger RNA (mRNA) technology.

Camber names Walgreens trading partner of the year

Camber Pharmaceuticals on Monday awarded Walgreens Boots Alliance in recognition of its status as the No. 1 trading partner for 2016-2017.

Camber names Associated Pharmacies trading partner of the year

Camber Pharmaceuticals on Monday awarded Associated Pharmacies in recognition of its status as the No. 1 trading partner for 2016–2017.

Leafbuyer Technologies Announces Renewed Partnership with The Denver Post’s Cannabist

The partnership will continue the bond between two of the nation’s leading online cannabis platforms. Leafbuyer Technologies, Inc. (OTC: LBUY) (“Leafbuyer”), a leading cannabis technology platform, announced today that it has renewed its partnership with the


MUNDELEIN, Ill., Aug. 22, 2017 /PRNewswire/ -- DOUGLAS MEDICAL PRODUCTS will provide sales and technical support for the expansion of MELITEK's full line of high quality polymer compounds. This Agreement expands MELITEK's global leadership into North America, providing direct access to their next generation polymer solutions for healthcare applications.   Doug Johnson, CEO of DOUGLAS...

Grid Therapeutics Signs Exclusive License Agreement to Develop a Novel Immuno-Oncology Antibody

Grid Therapeutics, LLC, an oncology-focused biotechnology company announced the execution of an exclusive license agreement with Duke University to develop the first human derived antibody as a targeted immunotherapy for cancer. Under the agreement, Grid has acquired the exclusive rights to all intellectual property, including

ALK readies Odactra launch after Merck exit

The Danish drugmaker is ready to launch its house dust mite treatment after its big pharma partner pulled out of the collaboration in 2016.

CRISPR Therapeutics, MGH Partner to Develop T-Cell Cancer Therapies

CRISPR Therapeutics and Massachusetts General Hospital Cancer Center (MGHCC) said today they will develop novel T cell therapies for blood and solid tumors by using CRISPR/Cas9 gene editing to improve upon current T cell treatments, through a collaboration whose value was not disclosed. CRISPR Therapeutics said the collaboration represents its latest step toward developing immuno-oncology trea...

Orion Health and NextGate Renew Partnership

SCOTTSDALE, Ariz., Aug. 22, 2017 /PRNewswire/ -- Orion Health, a leader in population health management, has extended its partnership with NextGate, a company with expertise in patient and organization identity management. "NextGate solutions, combined with Orion Health's industry leading precision health platform, creates a significant offering for the healthcare IT market," said Wayne ...

Successful Pilot Inspires 5-Year Partnership between Bloomz and Ohio AAP

REDMOND, Wash., Aug. 22, 2017 /PRNewswire/ -- The award-winning parent and teacher communication mobile app Bloomz ( today announced an exclusive 5-year partnership with the Ohio Chapter, American Academy of Pediatrics (Ohio AAP), with funding provided by Cardinal Health Foundation. The partnership is focused on educating parents and caregivers regarding health, wellness, and safety...

The Tolan Group Expands it's Reach in Healthcare Human Capital

ST. AUGUSTINE, Fla., Aug. 22, 2017 /PRNewswire/ -- The Tolan Group – A Member of the Sanford Rose Associates Network of Offices, a leader in healthcare executive search, has announced that Diana Ramsay, a seasoned behavioral healthcare executive has joined the firm to lead its Behavioral Health, Human Services, Family Services and Substance Abuse Practice. "Behavioral health and the other se...

Lilly to Use Topas Platform in Immunology Collaboration

Eli Lilly will use Topas Therapeutics’ antigen-specific tolerance induction platform to develop new treatments, with an initial focus on external antigens believed to induce inflammation and/or autoimmune disease, Topas said today. The companies have signed a multi-year research and option agreement whose value was not disclosed. Topas did say, however, that it will receive from Lilly R&...

RedHill Biopharma (RDHL) - First sales of GI specialty products

Edison Investment Research - Pharmaceutical & healthcare - RedHill Biopharma : RedHill’s strategy to diversify into commercial specialty pharma business has born first fruits with initial sales booked in Q217, in line with previously guided timelines to initiate the marketing activities. The US organisation is now fully set up and markets two GI products: Donnatal (co-promoted with Concordia...

Legalization of Cannabis Products Push Growth Projections

NEW YORK, August 22, 2017 /PRNewswire/ -- According to a report by Grand View Research, the global medical cannabis market is projected to reach a value of USD 55.8 billion by 2025. After the elections of 2016, Washington D.C., along with 28 states have legalized cannabis for medical use. The growing number of states and countries receiving approval for use in therapeutic application...

Eli Lilly Partners with German Biotech Against Autoimmune Disease

Topas Therapeutics has signed a multi-year agreement with Eli Lilly to develop drug candidates for antigen-specific immunotherapy. The young Topas Therapeutics, a spin off from Evotec launched just last year, has managed to sign a research collaboration deal with big pharma Eli Lilly. ... This awesome article Eli Lilly Partners with German Biotech Against Autoimmune Disease appeared first on La...

Canadian Cannabis Leaders Sharpen Focus on Increasing Yield, Plant Quality

NEW YORK, August 22, 2017 /PRNewswire/ -- Growing marijuana in North America, for obvious reasons, has historically been an underground affair. Amid growing legalization in favor of recreational and medicinal use, growing cannabis on mass scale is rapidly becoming a necessity for companies in a burgeoning industry driven by incredible consumer demand. Canada is ahead of the United States in th...

NHS Trusts Take ‘Giant Leap’ in Connecting Diagnostics Across Hospitals

Two NHS trusts in the North West of England have taken the lead in breaking down barriers between diagnostic departments and frontline clinical staff, in a move that healthcare professionals say is changing how they can view and diagnose patients, and that is improving collaboration between hospitals across the region. University Hospitals of Morecambe Bay NHS Foundation Trust has become the firs...

GDC-0084 Progress Update: On Track for Phase II Commencement in 2017

SYDNEY, Aug. 22, 2017 /PRNewswire/ -- Novogen Ltd (ASX: NRT; NASDAQ: NVGN), an Australian oncology drug development company, is pleased to provide an update to investors on progress with its clinical-stage drug development candidate, GDC-0084. GDC-0084 was in-licensed from Genentech, Inc in October 2016, after completion of a phase I clinical trial in advanced glioma. Key Highlights ...

Quick Search

review and buy Collaborations in biotechnology market research data and corporate reports here